000 01663 a2200445 4500
005 20250514070215.0
264 0 _c20031007
008 200310s 0 0 eng d
022 _a0066-4804
024 7 _a10.1128/AAC.47.6.1777-1783.2003
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aFarrell, D J
245 0 0 _aMacrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study.
_h[electronic resource]
260 _bAntimicrobial agents and chemotherapy
_cJun 2003
300 _a1777-83 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAnti-Bacterial Agents
_xpharmacology
650 0 4 _aDNA, Bacterial
_xchemistry
650 0 4 _aDrug Resistance, Bacterial
650 0 4 _aElectrophoresis, Gel, Pulsed-Field
650 0 4 _aHumans
650 0 4 _aMacrolides
650 0 4 _aPneumococcal Infections
_xmicrobiology
650 0 4 _aPoint Mutation
_xgenetics
650 0 4 _aPolymerase Chain Reaction
650 0 4 _aRNA, Bacterial
_xchemistry
650 0 4 _aRNA, Ribosomal, 23S
_xchemistry
650 0 4 _aRNA-Binding Proteins
_xchemistry
650 0 4 _aRibosomal Proteins
_xchemistry
650 0 4 _aSequence Analysis, DNA
650 0 4 _aStreptococcus pneumoniae
_xdrug effects
700 1 _aDouthwaite, S
700 1 _aMorrissey, I
700 1 _aBakker, S
700 1 _aPoehlsgaard, J
700 1 _aJakobsen, L
700 1 _aFelmingham, D
773 0 _tAntimicrobial agents and chemotherapy
_gvol. 47
_gno. 6
_gp. 1777-83
856 4 0 _uhttps://doi.org/10.1128/AAC.47.6.1777-1783.2003
_zAvailable from publisher's website
999 _c12547568
_d12547568